![](/img/cover-not-exists.png)
A combination of PPAR-γ agonists and HMG CoA reductase inhibitors (statins) as a new therapy for the conservative treatment of AAS (aortic aneurysm syndromes)
Gian Pio Sorice, Franco FolliVolume:
73
Year:
2009
Language:
english
DOI:
10.1016/j.mehy.2009.04.058
File:
PDF, 138 KB
english, 2009